Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 1/20 | 0.60 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 3/20 | 0.46 |
| ▸ | PPARG | P37231 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | AGXT | P21549 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13802342 | 0.93 | SLC6A2 (0.54) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL2375800 | 0.86 | TAAR1 (0.46) | SLC6A2SLC6A3SLC6A4TAAR1CYP2A6 | |
| SCHEMBL9481333 | 0.84 | SLC6A4 (0.58) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL2763601 | 0.82 | SLC6A4 (0.56) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL1253523 | 0.80 | SLC6A4 (0.54) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL4161150 | 0.80 | SLC6A2 (0.61) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL19616116 | 0.80 | SLC6A4 (0.54) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL4158699 | 0.80 | SLC6A2 (0.61) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL5099590 | 0.80 | SLC6A4 (0.54) | SLC6A2SLC6A3SLC6A4IDO1PPARG | |
| SCHEMBL10763436 | 0.80 | SLC6A4 (0.67) | SLC6A2SLC6A3SLC6A4IDO1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275077-A1 | Methods of Obtaining Optically Active Epoxides and Vicinal Diols from Styrene Oxides | OXYRANE (UK) LIMITED (GB) | 2009-11-05 | — | — | US | disclosed |
| US-20070281339-A1 | Methods For Obtaining Optically Active Epoxides and Vicinal Diols From Styrene Oxides | OXYRANE UK LIMITED (GB) | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275077-A1 | Methods of Obtaining Optically Active Epoxides and Vicinal Diols from Styrene Oxides | EPHX2, EPHX1, DERA | SLC6A2 2550/4885SLC6A3 2900/4885SLC6A4 2791/4885 |
| US-20070281339-A1 | Methods For Obtaining Optically Active Epoxides and Vicinal Diols From Styrene Oxides | DERA, ERG28, EPHX2 | SLC6A2 3106/4885SLC6A3 2916/4885SLC6A4 3169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.